Status:
COMPLETED
Atropine-effect During Propofol/Remifentanil Induction
Lead Sponsor:
University Medical Center Groningen
Conditions:
Anesthesia-induced Negative Hemodynamic Effects
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Remifentanil is a widely used potent intravenous opioid with the advantage of having a short time of action. Compared to other opiates however remifentanil generates more intense hemodynamic side-effe...
Eligibility Criteria
Inclusion
- Patients requiring general anaesthesia;
- Patient's age ≥ 18 years and older;
- Patient and surgical procedure appropriate for treatment with either sufentanil or remifentanil.
Exclusion
- Patient's refusal;
- Pregnancy;
- Patient's age \< 18 years;
- Patients in which atropine is contra-indicated, such as severe aortic valve stenosis, hypertrophic cardiomyopathy or coronary artery disease.
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01871922
Start Date
October 1 2012
End Date
June 1 2013
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9713GZ